Iradimed Co (IRMD)

Currency in USD
99.81
-0.03(-0.03%)
Closed·
99.810.00(0.00%)
·
IRMD is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
99.36102.34
52 wk Range
47.48107.90
Key Statistics
Prev. Close
99.84
Open
99.36
Day's Range
99.36-102.34
52 wk Range
47.48-107.9
Volume
58.25K
Average Volume (3m)
77.87K
1-Year Change
80.717%
Book Value / Share
7.44
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
IRMD Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
120.00
Upside
+20.23%
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a high P/E ratio relative to near-term earnings growth

Iradimed Co News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Sell
Moving Averages
Sell

Iradimed Co Company Profile

IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices and related accessories, and disposables and services in the United States and internationally. The company offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; MRI compatible patient vital signs monitoring system; and 3600 FMD1 with remote alarm logging unit ferromagnetic detection device. It also provides non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring with sensors and accessories. The company serves hospitals, acute care facilities, and outpatient imaging centers. It sells its products through direct field sales representatives, regional sales directors, clinical application specialists, and independent distributors. The company was incorporated in 1992 and is headquartered in Orlando, Florida.

Iradimed Co Earnings Call Summary for Q4/2025

  • IRadimed Co reported Q4 2025 EPS of $0.54 (12.5% above forecasts) and revenue of $22.7 million (5.05% above expectations), marking its 18th consecutive quarter of record revenue.
  • The company's stock surged 9.36% in pre-market trading to $95.97, reflecting investor confidence in its continued growth trajectory.
  • Full-year 2025 revenue reached $83.8 million (up 14% YoY) with GAAP diluted EPS of $1.75 (up 17% YoY) and strong gross margins of 77%.
  • Management expects significant growth in H2 2026 with the launch of the 3870 MR IV pump system, targeting a $100 million revenue run rate.
  • IRadimed plans market expansion into Europe by end of 2026 and Japan by summer 2027, with CEO Roger Susi projecting a $50 million annual revenue run rate for pumps.
Last Updated: 10/02/2026, 16:50
Read Full Transcript

Compare IRMD to Peers and Sector

Metrics to compare
IRMD
Peers
Sector
Relationship
P/E Ratio
56.5x48.4x−0.5x
PEG Ratio
3.390.280.00
Price/Book
13.4x12.5x2.6x
Price / LTM Sales
15.1x3.2x3.3x
Upside (Analyst Target)
20.2%11.1%47.0%
Fair Value Upside
Unlock−3.7%6.1%Unlock

Analyst Ratings

2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 120.00
(+20.23% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Roth/MKM
Buy120.00+20.23%98.00Maintain10/02/2026
Lake Street Capital Markets
Buy120.00+20.23%-Maintain10/02/2026
Lake Street Capital Markets
Buy100.00+0.19%-Maintain03/11/2025

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 1.75%
Dividend Yield
0.80%
Industry Median 1.39%
Annualised payout
0.80
Paid unevenly
5-Years Growth
-
Growth Streak

Earnings

Latest Release
Feb 10, 2026
EPS / Forecast
0.54 / 0.48
Revenue / Forecast
22.69M / 21.60M
EPS Revisions
Last 90 days

People Also Watch

268.41
ESE
-1.59%
56.76
STEP
+0.34%
49.20
CRVL
+4.08%
322.71
PIPR
+0.43%

FAQ

What Is the Iradimed Co (IRMD) Share Price Today?

The live Iradimed Co share price today is 99.81

What Stock Exchange Does Iradimed Co (IRMD) Trade On?

Iradimed Co is listed and trades on the Nasdaq Stock Exchange.

What Is the Ticker (Stock Symbol) for Iradimed Co?

The stock symbol (also called a 'ticker') for Iradimed Co is "IRMD."

Does Iradimed Co Pay Dividends? What’s The Current IRMD Dividend Yield?

Yes, IRMD Pays Dividends to its Shareholders. The current Iradimed Co dividend yield is 0.8%.

What Is the Current Iradimed Co Market Cap?

As of today, Iradimed Co market capitalisation is 1.27B.

What Is Iradimed Co's (IRMD) Earnings Per Share (TTM)?

The Iradimed Co EPS is currently 1.75 (Trailing Twelve Months).

When Is the Next Iradimed Co Earnings Date?

Iradimed Co's next earnings report will be released on 24/04/2026.

Is IRMD a Buy or Sell From a Technical Analyst Perspective?

Based on today's Iradimed Co moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has Iradimed Co Stock Split?

Iradimed Co has split 0 times. (See the IRMD stock split history page for full effective split date and price information.)

How Many Employees Does Iradimed Co Have?

Iradimed Co has 160 employees.

What is the current trading status of Iradimed Co (IRMD)?

As of 14 Feb 2026, Iradimed Co (IRMD) is trading at a price of 99.81, with a previous close of 99.84. The stock has fluctuated within a day range of 99.36 to 102.34, while its 52-week range spans from 47.48 to 107.90.

What Is Iradimed Co (IRMD) Price Target According to Analysts?

The average 12-month price target for Iradimed Co is USD120.00, with a high estimate of USD120 and a low estimate of USD120. 2 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +20.23% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.